These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 8222521

  • 1. Polymyalgia rheumatica.
    Lestico MR, Boh LE, Schuna AA.
    Clin Pharm; 1993 Aug; 12(8):571-80. PubMed ID: 8222521
    [Abstract] [Full Text] [Related]

  • 2. Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis.
    Bahlas S, Ramos-Remus C, Davis P.
    J Rheumatol; 1998 Jan; 25(1):99-104. PubMed ID: 9458211
    [Abstract] [Full Text] [Related]

  • 3. The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain.
    Gonzalez-Gay MA, Garcia-Porrua C, Salvarani C, Olivieri I, Hunder GG.
    J Rheumatol; 2000 Sep; 27(9):2179-84. PubMed ID: 10990231
    [Abstract] [Full Text] [Related]

  • 4. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
    González-Gay MA, García-Porrúa C, Vázquez-Caruncho M.
    J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
    [Abstract] [Full Text] [Related]

  • 5. Polymyalgia rheumatica and giant cell arteritis--An ophthalmic emergency.
    Durkin SR, Athanasiov PA, Crompton JL.
    Aust Fam Physician; 2006 Nov; 35(11):889-91. PubMed ID: 17099810
    [Abstract] [Full Text] [Related]

  • 6. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
    Martinez-Taboada VM, Bartolome MJ, Fernandez-Gonzalez MD, Blanco R, Rodriguez-Valverde V, Lopez-Hoyos M.
    Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
    [Abstract] [Full Text] [Related]

  • 7. Polymyalgia rheumatica.
    Salvarani C, Cantini F, Boiardi L, Hunder GG.
    Best Pract Res Clin Rheumatol; 2004 Oct; 18(5):705-22. PubMed ID: 15454128
    [Abstract] [Full Text] [Related]

  • 8. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
    Martinez-Taboada VM, Blanco R, Fito C, Pacheco MJ, Delgado-Rodriguez M, Rodriguez-Valverde V.
    Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
    [Abstract] [Full Text] [Related]

  • 9. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study.
    González-Gay MA, García-Porrúa C, Vázquez-Caruncho M, Dababneh A, Hajeer A, Ollier WE.
    J Rheumatol; 1999 Jun; 26(6):1326-32. PubMed ID: 10381051
    [Abstract] [Full Text] [Related]

  • 10. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
    Askling J, Klareskog L, Hjalgrim H, Baecklund E, Björkholm M, Ekbom A.
    Ann Rheum Dis; 2005 Dec; 64(12):1765-8. PubMed ID: 15843445
    [Abstract] [Full Text] [Related]

  • 11. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis.
    Chakravarty K, Pountain G, Merry P, Byron M, Hazleman B, Scott DG.
    J Rheumatol; 1995 Sep; 22(9):1694-7. PubMed ID: 8523347
    [Abstract] [Full Text] [Related]

  • 12. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.
    Salvarani C, Casali B, Boiardi L, Ranzi A, Macchioni P, Nicoli D, Farnetti E, Brini M, Portioli I.
    J Rheumatol; 2000 May; 27(5):1215-21. PubMed ID: 10813290
    [Abstract] [Full Text] [Related]

  • 13. Longterm therapy in polymyalgia rheumatica: effect of coexistent temporal arteritis.
    Narváez J, Nolla-Solé JM, Clavaguera MT, Valverde-García J, Roig-Escofet D.
    J Rheumatol; 1999 Sep; 26(9):1945-52. PubMed ID: 10493675
    [Abstract] [Full Text] [Related]

  • 14. [Polymyalgia rheumatica and temporal arteritis].
    Vos PA, Bijlsma JW, Derksen RH.
    Ned Tijdschr Geneeskd; 2005 Aug 27; 149(35):1932-7. PubMed ID: 16159030
    [Abstract] [Full Text] [Related]

  • 15. [Rheumatic polymyalgia].
    Calvo Romero JM, Ramos Salado JL, Pérez Miranda M.
    An Med Interna; 2000 Jan 27; 17(1):42-6. PubMed ID: 10730406
    [Abstract] [Full Text] [Related]

  • 16. [Polymyalgia rheumatica and giant cell arteritis: recent data and current situation].
    Announ N, Guerne PA.
    Rev Med Suisse; 2008 Mar 19; 4(149):696-8, 701. PubMed ID: 18472729
    [Abstract] [Full Text] [Related]

  • 17. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
    Schmidt J, Warrington KJ.
    Drugs Aging; 2011 Aug 01; 28(8):651-66. PubMed ID: 21812500
    [Abstract] [Full Text] [Related]

  • 18. Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment.
    Martinez-Taboada VM, Alvarez L, RuizSoto M, Marin-Vidalled MJ, Lopez-Hoyos M.
    Cytokine; 2008 Nov 01; 44(2):207-20. PubMed ID: 18986814
    [Abstract] [Full Text] [Related]

  • 19. Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications.
    Espinoza LR, Jara LJ, Silveira LH, Martínez-Osuna P, Zwolinska JB, Kneer C, Aguilar JL.
    Am J Med; 1991 Apr 01; 90(4):474-8. PubMed ID: 2012088
    [Abstract] [Full Text] [Related]

  • 20. [Rheumatic polymyalgia and temporal arteritis. Case contribution and bibliographic review].
    Manganelli P, Mercadanti M, Nervetti A, Ambanelli U.
    Minerva Med; 1987 Mar 15; 78(5):287-96. PubMed ID: 3822219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.